Lannett launches 2 genericsVenlafaxine ER tablets, 150 mg and 225 mg, and lidocaine topical solution 4% had a market value of roughly $150 million and $17 million, respectively, for the 12 months ended November 2019. BestRx announces scripClip interfacePerceptiMed's scripClip is designed to speed up the prescription dispensing process at will-call. Allergan reaches $300M settlement in Loestrin, Minastrin suit Warner Chilcott and Watson subsidiaries will pay approximately $300 million under settlement agreements. Walgreens earns enterprise-wide URAC Specialty Pharmacy accreditation Walgreens has earned the first enterprise-wide URAC Specialty Pharmacy accreditation for its network of more than 300 community specialty pharmacies. Daiichi Sankyo obtains FDA approval for Enhertu Daiichi Sankyo's Enhertu provides a new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies. Publix Pharmacy fills 100 millionth free prescription Publix Pharmacy recently filled its 100 millionth free prescription as part of its free medication program. Adamas settles patent litigation dispute with Sandoz Sandoz will be allowed to launch a generic version of Gocovri on March 4, 2030 or earlier under certain circumstances. Novadoz gets FDA nod for generic Uloric The Febuxostat brand had a market value of over $430 million over the previous 12 months. Micro Labs, Mylan get FDA OK for generic Eliquis The generic is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Q&A: Greg Wasson discusses his recent investment in Innovation Drug Store News spoke with Greg Wasson about recent developments and his vision for Innovation’s future growth. First Previous 420 421 422 423 424 Next Last